Logo-apb
Adv Pharm Bull. 2020;10(3): 334-337. doi: 10.34172/apb.2020.041
PMID: 32665891        PMCID: PMC7335992

Editorial

Safe Drugs Versus Innovative Drugs (Can We Have Both?)

Vera Lúcia Raposo 1 * ORCID

Cited by CrossRef: 2


1- Bekhite M, Schulze P. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective. Cells. 2021;10(12):3483 [Crossref]
2- Raposo V. Meu corpo, minha escolha... a saúde de todos: batalhas sobre vacinação em tempo de pandemia. Cad Ibero Am Direito Sanit. 2021;10(Suplemento):101 [Crossref]
3- Dixon A, Sladden M, Zouboulis C, Popescu C, Nirenberg A, Steinman H, Longo C, Dixon Z, Thomas J. Reply to Pennington, T.E.; Thompson, J.F. Sentinel Node Biopsy in Melanoma Remains a Valuable Clinical Tool. Comment on “Dixon et al. Primary Cutaneous Melanoma—Management in 2024. J. Clin. Med. 2024, 13, 1607”. JCM. 2025;14(1):216 [Crossref]